News

↳ Here we publish news related to Atnotera's investments
2021-04-06

CTR buys preclinical toxic company

Center for Translational Research Sweden AB (CTR) acquires Toxicology Knowledge Team Sweden AB (TKT), which further strengthens the CTR group with optimized toxicological support. Since April 1, TKT has been a wholly owned subsidiary of the holding company CTR.

Read the full article →
2021-04-06

Rönnberg & Partners AB has in March 2021 transferred 100% of the shares in the subsidiaries AB Videdals Privatskolor and Montemini i Helsingborgs Montessoriskola AB to Atvexa AB.

Rönnberg & Partners AB has in March 2021 transferred 100% of the shares in the subsidiaries AB Videdals Privatskolor and Montemini i Helsingborgs Montessoriskola AB to Atvexa AB.

Read the full article →
2021-01-11

Karin Meyer becomes new CEO of Center for Translational Research Sweden AB (CTR)

Karin Meyer becomes new CEO of Center for Translational Research Sweden AB (CTR)

Read the full article →
2020-12-07

First day of trading on Nasdaq Stockholm in Atvexa's B-share

The first day of trading in Atvexa's Class B shares on Nasdaq Stockholm is tomorrow, December 8, 2020. The last trading day for Atvexa's Class B shares on Nasdaq First North Growth Market was today, December 7, 2020. The company's Class B share will be traded with both unchanged short name (ATVEXA B) and ISIN code (SE0010599704).

Read the full article →
2020-02-01

Atviva raises SEK 33 million in new capital

Atnotera has subscribed for a new share issue in Atviva AB in connection with Atviva's acquired 100% of the shares in AB Vårdstyrkan in Stockholm. After the issue, Atnotera has 89% of the votes and capital in Atviva.

Read the full article →
2019-11-10

Center for Translational Research AB acquires GLP (Good Laboratory Practice) unit from Recipharm OT Chemistry AB

CTC and Recipharm, the leading CDMO (Contract Development and Manufacturing Organization) companies in the pharmaceutical industry, have strengthened their collaboration through the divestment of Recipharm's GLP laboratory to the Center for Translational Research AB (CTR).

Read the full article →
2019-10-26

New Board of Directors and Chairman of Fenix Funeral AB

At the Annual General Meeting of Fenix Begravning AB, Stefan Mahlstein was appointed new Chairman of the Board and Ralph Riber as new board member.

Read the full article →
2019-10-23

New Board of Directors and Chairman of Atleva Specialist Care AB

Camilla's most recent role as head of a municipal business where she was responsible for the care of the elderly. Prior to this, she worked for more than 15 years at Attendo.

Read the full article →
2019-09-17

The Board of Directors of Atleva Specialist Care AB appoints Camilla Sjögren as new CEO

Camilla's most recent role as head of a municipal business where she was responsible for the care of the elderly. Prior to this, she worked for more than 15 years at Attendo.

Read the full article →
2018-12-15

Atvexa AB (publ) Atvexa has signed an agreement to acquire 100 percent of the shares in ULNA AS

The sellers are the owners and founders of the preschool group ULNA, with operations in Norway, Sweden and Germany.

Read the full article →
2018-09-08

All shares in City Office in WTC sold

Atnotgruppen has divested all shares in City Office in WTC AB in two stages to the World Trade Center in Gothenburg AB.

Read the full article →
2018-05-05

Fenix Funeral raises SEK 10 million in new capital

The digital funeral home Fenix is modernizing the industry by digitising as much as possible of funeral planning – the company is now traveling SEK 10 million in venture capital from various investors.

Read the full article →
2017-11-29

Listing of Atvexa on Nasdaq First North

The Board of Directors of Atvexa AB (publ) ("Atvexa", "The Company", "The Group" or the "AtvexaGruppen"), one of the leading players in the swedish education market, has together with Selling Shareholders1 decided to carry out a spread of ownership of the Company's shares through a sale of new and existing Class B shares (the "Offer").

Read the full article →
2017-08-28

Atnotera AB has become a partner in Nolhaga Hem AB

The acquisition has been made through subscription of new share issue, which gives Atnot 39% of the shares in Nolhaga Hem. Nolhaga Hem is a new chain of stores in home textiles and furnishings.

Read the full article →
2016-11-10

Atnotera AB has become a partner in the UK company My Clinical Outcomes Ltd.

The acquisition is made by subscription of a rights issue that gives Atnot AB 12% of the shares in My Clinical Outcomes Ltd.

Read the full article →
2016-04-23

Through its subsidiary MLPW Invest AB, Atnotera AB has become a partner in the Center for Translational Research AB.

The acquisition is made by subscription of new share issue that gives MLPW Invest AB a total of 33% of the shares in the Center for Translational Research AB

Read the full article →
2015-08-25

Atnotera AB has through subsidiaries become a partner in Fenix Begravning AB.

The acquisition is made through a combination of the purchase of shares and subscription of rights issues. The issue gives the Atnote Group 25% of the shares in Fenix Begravning AB.

Read the full article →
2014-06-14

Through subsidiaries, Atnotera AB has signed a rights issue in The City Office in WTC AB.

The issue gives the Atnot Group 50% of the shares in City Office. The City Office of the World Trade Center has been running office hotels and office services since 1990. The company works with companies of all sizes and among our tenants and virtual customers there are many successful Swedish and international companies.

Read the full article →
2013-04-19

The health pharmacy is sold to Apoteket Hjärtat

VAINAB, together with Priveq Investment and Investor Growth Capital, has entered into an agreement with Apotek Hjärtat to divest its holding in the Care Pharmacy in Norden AB (Health Pharmacy)

Read the full article →